What is the net worth of AstraZeneca?

AstraZeneca net worth as of August 19, 2021 is $184.16B. AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products.

What is AstraZeneca PLC ORD?

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory.

Who is the CEO of AstraZeneca?

Pascal Soriot (1 Oct 2012–)
AstraZeneca/CEO

Is AstraZeneca a good company?

On average, employees at AstraZeneca give their company a 4.1 rating out of 5.0 – which is 5% higher than the average rating for all companies on CareerBliss. The happiest AstraZeneca employees are Specialty Sales Representatives submitting an average rating of 5.0 and Clinical Research Associates with a rating of 4.6.

Is AZN stock a buy?

No, AstraZeneca stock isn’t a buy right now. Savvy investors buy when a stock breaks out and remains within 5% of its entry. Shares are still forming a new flat base. There are some caveats to AZN stock.

Where is AstraZeneca headquarters located?

Cambridge, United Kingdom
AstraZeneca/Headquarters

How much does the CEO of AstraZeneca make?

AstraZeneca CEO Pascal Soriot made headlines when he moaned about the poor pay he took home for 2017, forced to live on about $13 million in total compensation. That made him one of the worst paid — though certainly not the worst — big pharma execs in the world.

Does AstraZeneca pay well?

Employees at AstraZeneca earn different salaries depending on their region. The city with the highest average salary is South San Francisco, CA, where employees earn an average salary of $105,840. AstraZeneca Employees in Bothell, WA don’t earn quite as much.

How many employees does AstraZeneca have?

Latest Updates

Employees (est.) (Dec 2020)	76,100	(+8%)
Website Visits (Mar 2021)	2 m
Revenue (FY, 2019)	$24.4 B	(+11%)
Share Price (Aug 2021)	£83	(+2%)
Cybersecurity rating	B	More

Is AZN a buy Zacks?

In this example, we are using the consensus earnings estimate for the Current Fiscal Year (F1)….Momentum Scorecard. More Info.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	25.60%
2	Buy	19.21%
3	Hold	10.85%
4	Sell	6.62%

Will AZN go up?

AstraZeneca PLC (NASDAQ:AZN) The 22 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 68.33, with a high estimate of 76.87 and a low estimate of 47.99. The median estimate represents a +15.85% increase from the last price of 58.98.

What was the stock price of AstraZeneca in March?

AstraZeneca PLC has sprinted higher the past few weeks in what looks to be a small a-b move or measured move pattern. In this daily bar chart of AZN, below, we can see that prices rallied about $7 in the first “leg up” from the March low – $38 to $45.

What is the name of AstraZeneca’s blood cancer drug?

AstraZeneca (AZN) to initiate enrollment in a clinical study to evaluate its blood cancer drug, Calquence, as a potential treatment for patients hospitalized with COVID-19 infection. The Zacks Analyst Blog Highlights: Apple, Amazon, AstraZeneca, JPMorgan and Wells Fargo

When do the first AstraZeneca shots come out?

The first vials are due to be produced on June 15 and up to six weeks will be needed for checks before they are put to use in vaccination centres, Health Minister Hala Zayed told the private MBC Masr TV channel late on Sunday.

What is the relative strength rating of AstraZeneca?

The daily On-Balance-Volume (OBV) line has turned upward with the price action and is not far from making a new high. AstraZeneca on Monday said it will test a new coronavirus treatment. The pharmaceutical giant saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 87 to 92.

How is the market cap of AstraZeneca calculated?

Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. AstraZeneca market cap as of June 10, 2021 is $151.18B.

Who is the holding company for AstraZeneca plc?

AstraZeneca PLC operates as a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products.

What kind of products does AstraZeneca make?

The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection.